543 related articles for article (PubMed ID: 15961505)
1. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity.
Sentis S; Le Romancer M; Bianchin C; Rostan MC; Corbo L
Mol Endocrinol; 2005 Nov; 19(11):2671-84. PubMed ID: 15961505
[TBL] [Abstract][Full Text] [Related]
2. FHL2, UBC9, and PIAS1 are novel estrogen receptor alpha-interacting proteins.
Kobayashi S; Shibata H; Yokota K; Suda N; Murai A; Kurihara I; Saito I; Saruta T
Endocr Res; 2004 Nov; 30(4):617-21. PubMed ID: 15666801
[TBL] [Abstract][Full Text] [Related]
3. The transcriptional activity of co-activator AIB1 is regulated by the SUMO E3 ligase PIAS1.
Li S; Yang C; Hong Y; Bi H; Zhao F; Liu Y; Ao X; Pang P; Xing X; Chang AK; Xiao L; Zhang Y; Wu H
Biol Cell; 2012 May; 104(5):287-96. PubMed ID: 22283414
[TBL] [Abstract][Full Text] [Related]
4. Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation.
Mascle XH; Lussier-Price M; Cappadocia L; Estephan P; Raiola L; Omichinski JG; Aubry M
J Biol Chem; 2013 Dec; 288(51):36312-27. PubMed ID: 24174529
[TBL] [Abstract][Full Text] [Related]
5. SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
Wang CM; Brennan VC; Gutierrez NM; Wang X; Wang L; Yang WH
J Cell Biochem; 2013 Mar; 114(3):589-98. PubMed ID: 22991139
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a C-Terminal SUMO-Interacting Motif Present in Select PIAS-Family Proteins.
Lussier-Price M; Mascle XH; Cappadocia L; Kamada R; Sakaguchi K; Wahba HM; Omichinski JG
Structure; 2020 May; 28(5):573-585.e5. PubMed ID: 32348746
[TBL] [Abstract][Full Text] [Related]
7. A Fluorescent In Vitro Assay to Investigate Paralog-Specific SUMO Conjugation.
Eisenhardt N; Chaugule VK; Pichler A
Methods Mol Biol; 2016; 1475():67-78. PubMed ID: 27631798
[TBL] [Abstract][Full Text] [Related]
8. SUMOylation of RORalpha potentiates transcriptional activation function.
Hwang EJ; Lee JM; Jeong J; Park JH; Yang Y; Lim JS; Kim JH; Baek SH; Kim KI
Biochem Biophys Res Commun; 2009 Jan; 378(3):513-7. PubMed ID: 19041634
[TBL] [Abstract][Full Text] [Related]
9. A novel mechanism whereby BRCA1/1a/1b fine tunes the dynamic complex interplay between SUMO-dependent/independent activities of Ubc9 on E2-induced ERalpha activation/repression and degradation in breast cancer cells.
Xu J; Watkins T; Reddy A; Reddy ES; Rao VN
Int J Oncol; 2009 Apr; 34(4):939-49. PubMed ID: 19287951
[TBL] [Abstract][Full Text] [Related]
10. SUMOylation can regulate the activity of ETS-like transcription factor 4.
Kaikkonen S; Makkonen H; Rytinki M; Palvimo JJ
Biochim Biophys Acta; 2010 Aug; 1799(8):555-60. PubMed ID: 20637912
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus E4-ORF3 Targets PIAS3 and Together with E1B-55K Remodels SUMO Interactions in the Nucleus and at Virus Genome Replication Domains.
Higginbotham JM; O'Shea CC
J Virol; 2015 Oct; 89(20):10260-72. PubMed ID: 26223632
[TBL] [Abstract][Full Text] [Related]
12. Protein inhibitor of activated STAT3 (PIAS3) protein promotes SUMOylation and nuclear sequestration of the intracellular domain of ErbB4 protein.
Sundvall M; Korhonen A; Vaparanta K; Anckar J; Halkilahti K; Salah Z; Aqeilan RI; Palvimo JJ; Sistonen L; Elenius K
J Biol Chem; 2012 Jun; 287(27):23216-26. PubMed ID: 22584572
[TBL] [Abstract][Full Text] [Related]
13. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
[TBL] [Abstract][Full Text] [Related]
14. SUMO E3 ligases are expressed in the retina and regulate SUMOylation of the metabotropic glutamate receptor 8b.
Dütting E; Schröder-Kress N; Sticht H; Enz R
Biochem J; 2011 Apr; 435(2):365-71. PubMed ID: 21288202
[TBL] [Abstract][Full Text] [Related]
15. SUMO pathway components as possible cancer biomarkers.
Mattoscio D; Chiocca S
Future Oncol; 2015; 11(11):1599-610. PubMed ID: 26043214
[TBL] [Abstract][Full Text] [Related]
16. CLOCK is a substrate of SUMO and sumoylation of CLOCK upregulates the transcriptional activity of estrogen receptor-α.
Li S; Wang M; Ao X; Chang AK; Yang C; Zhao F; Bi H; Liu Y; Xiao L; Wu H
Oncogene; 2013 Oct; 32(41):4883-91. PubMed ID: 23160374
[TBL] [Abstract][Full Text] [Related]
17. Role for SUMO modification in facilitating transcriptional repression by BKLF.
Perdomo J; Verger A; Turner J; Crossley M
Mol Cell Biol; 2005 Feb; 25(4):1549-59. PubMed ID: 15684403
[TBL] [Abstract][Full Text] [Related]
18. Small ubiquitin-like modifier (SUMO) modification of zinc finger protein 131 potentiates its negative effect on estrogen signaling.
Oh Y; Chung KC
J Biol Chem; 2012 May; 287(21):17517-17529. PubMed ID: 22467880
[TBL] [Abstract][Full Text] [Related]
19. PIASy-mediated sumoylation of Yin Yang 1 depends on their interaction but not the RING finger.
Deng Z; Wan M; Sui G
Mol Cell Biol; 2007 May; 27(10):3780-92. PubMed ID: 17353273
[TBL] [Abstract][Full Text] [Related]
20. Regulation of nuclear receptor and coactivator functions by the carboxyl terminus of ubiquitin-conjugating enzyme 9.
Chang YL; Huang CJ; Chan JY; Liu PY; Chang HP; Huang SM
Int J Biochem Cell Biol; 2007; 39(5):1035-46. PubMed ID: 17336575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]